ExchangeDEX+
Buy CryptoMarketsSpotFuturesGOLDEarnEvent Center
More
Commodity Zero-Fee Gala
TEL AVIV, Israel, Feb. 10, 2026 /PRNewswire/ — Protai, www.protai.bio, an AI drug discovery startup, announced its participation in a series of major scientificTEL AVIV, Israel, Feb. 10, 2026 /PRNewswire/ — Protai, www.protai.bio, an AI drug discovery startup, announced its participation in a series of major scientific

Protai to showcase groundbreaking AIMS™ drug discovery platform and best-in-class PRT001 KAT6A degrader results at spring 2026 global conferences.

Author: AI Journal
Source: AI Journal
2026/02/10 18:47
2 min read
Major
MAJOR$0.08376-0.20%
BIO Protocol
BIO$0.0255-1.54%
Telcoin
TEL$0.002851-0.80%

TEL AVIV, Israel, Feb. 10, 2026 /PRNewswire/ — Protai, www.protai.bio, an AI drug discovery startup, announced its participation in a series of major scientific conferences this spring, where it will present significant advances in its AIMS™ proteomics-aware-AI drug discovery platform and breakthrough preclinical results of its best-in-class KAT6A degrader program.

  1. Protai’s upcoming spring 2026 conference presentations:
  2. HDX-MS conference Strasbourg, 9-13 March 2026, Dr. Anjana Shenoy, Head of Proteomics
  3. ACS2026, Atlanta, March 2026, Kirill Pevzner, CTO
  4. TPD summit Europe, London, March 2026, Eran Seger (CEO) & Kirill Pevzner (CTO)
  5. Drug discovery chemistry, San Diego, April 2026, Kirill Pevzner (CTO)
  6. AACR 2026, San Diego, April 2026, Eran Seger (CEO) & Kirill Pevzner (CTO)

Protai’s presentations will highlight the following key achievements:

  • AIMS™ Platform validated: Integration of AI-driven structural modeling with mass-spectrometry-based structural proteomics, which supported the lead optimization of the KAT6A Targeted Protein Degradation program.
  • PRT-001 best-in-class results: New in vivo results from the company’s KAT6A degrader program.

“By combining proteomics-driven experimental evidence with next-generation AI modeling, we are revealing opportunities that were previously invisible to classical drug discovery methods.” Said Eran Seger, Protai’s CEO.  “These upcoming presentations will showcase the power of combining experimental data and AI, and its outcome in rapidly generating highly effective drugs for huge clinical unmet needs. “

About Protai

Protai is an AI drug discovery company unlocking the therapeutic potential of protein complexes through structural proteomics. Unlike standard AI models that rely on static predictions, Protai’s AIMS™ platform maps dynamic protein interactions using proprietary experimental data, to model the function of protein complexes in the disease native state. Protai is leveraging this engine to advance an innovative internal drug pipeline, led by a best-in-class KAT6A degrader for the treatment of breast cancer and other solid tumors.

Contact:
contact@protai.bio

Cision View original content:https://www.prnewswire.com/news-releases/protai-to-showcase-groundbreaking-aims-drug-discovery-platform-and-best-in-class-prt001-kat6a-degrader-results-at-spring-2026-global-conferences-302683596.html

SOURCE Protai

Market Opportunity
Major Logo
Major Price(MAJOR)
$0.08376
$0.08376$0.08376
-0.02%
USD
Major (MAJOR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Young Republicans were more proud to be American under Obama than under Trump: data analyst

Young Republicans were more proud to be American under Obama than under Trump: data analyst

CNN data analyst Harry Enten sorts through revealing polls and surveys of American attitudes, looking for shifts, and his latest finding is an indictment of President
Share
Alternet2026/02/10 22:18
Disney Pockets $2.2 Billion For Filming Outside America

Disney Pockets $2.2 Billion For Filming Outside America

The post Disney Pockets $2.2 Billion For Filming Outside America appeared on BitcoinEthereumNews.com. Disney has made $2.2 billion from filming productions like ‘Avengers: Endgame’ in the U.K. ©Marvel Studios 2018 Disney has been handed $2.2 billion by the government of the United Kingdom over the past 15 years in return for filming movies and streaming shows in the country according to analysis of more than 400 company filings Disney is believed to be the biggest single beneficiary of the Audio-Visual Expenditure Credit (AVEC) in the U.K. which gives studios a cash reimbursement of up to 25.5% of the money they spend there. The generous fiscal incentives have attracted all of the major Hollywood studios to the U.K. and the country has reeled in the returns from it. Data from the British Film Institute (BFI) shows that foreign studios contributed around 87% of the $2.2 billion (£1.6 billion) spent on making films in the U.K. last year. It is a 7.6% increase on the sum spent in 2019 and is in stark contrast to the picture in the United States. According to permit issuing office FilmLA, the number of on-location shooting days in Los Angeles fell 35.7% from 2019 to 2024 making it the second-least productive year since 1995 aside from 2020 when it was the height of the pandemic. The outlook hasn’t improved since then with FilmLA’s latest data showing that between April and June this year there was a 6.2% drop in shooting days on the same period a year ago. It followed a 22.4% decline in the first quarter with FilmLA noting that “each drop reflected the impact of global production cutbacks and California’s ongoing loss of work to rival territories.” The one-two punch of the pandemic followed by the 2023 SAG-AFTRA strikes put Hollywood on the ropes just as the U.K. began drafting a plan to improve its fiscal incentives…
Share
BitcoinEthereumNews2025/09/18 07:20
Crypto Investors Install Golden Trump Bitcoin Statue Outside US Capitol

Crypto Investors Install Golden Trump Bitcoin Statue Outside US Capitol

TLDR Crypto investors erected a 12-foot golden statue of Trump holding Bitcoin outside the US Capitol on Wednesday The statue was placed on the National Mall as part of a Pump.fun livestream stunt and memecoin promotion Organizers said it honors Trump’s support for cryptocurrency and was timed with the Fed’s interest rate cut The statue [...] The post Crypto Investors Install Golden Trump Bitcoin Statue Outside US Capitol appeared first on CoinCentral.
Share
Coincentral2025/09/18 15:05